Objectives: To analyse the efficacy of acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee, with respect to pain relief, reduction of stiffness, and increased physical function during treatment; modifications in the consumption of diclofenac during treatment; and changes in the patient's quality of life.

Design: Randomised, controlled, single blind trial, with blinded evaluation and statistical analysis of results.

Setting: Pain management unit in a public primary care centre in southern Spain, over a period of two years.

Participants: 97 outpatients presenting with osteoarthritis of the knee.

Interventions: Patients were randomly separated into two groups, one receiving acupuncture plus diclofenac (n = 48) and the other placebo acupuncture plus diclofenac (n = 49).

Main Outcome Measures: The clinical variables examined included intensity of pain as measured by a visual analogue scale; pain, stiffness, and physical function subscales of the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index; dosage of diclofenac taken during treatment; and the profile of quality of life in the chronically ill (PQLC) instrument, evaluated before and after the treatment programme.

Results: 88 patients completed the trial. In the intention to treat analysis, the WOMAC index presented a greater reduction in the intervention group than in the control group (mean difference 23.9, 95% confidence interval 15.0 to 32.8) The reduction was greater in the subscale of functional activity. The same result was observed in the pain visual analogue scale, with a reduction of 26.6 (18.5 to 34.8). The PQLC results indicate that acupuncture treatment produces significant changes in physical capability (P = 0.021) and psychological functioning (P = 0.046). Three patients reported bruising after the acupuncture sessions.

Conclusions: Acupuncture plus diclofenac is more effective than placebo acupuncture plus diclofenac for the symptomatic treatment of osteoarthritis of the knee.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC529365PMC
http://dx.doi.org/10.1136/bmj.38238.601447.3ADOI Listing

Publication Analysis

Top Keywords

acupuncture diclofenac
16
treatment osteoarthritis
12
osteoarthritis knee
12
acupuncture
8
acupuncture complementary
8
complementary therapy
8
therapy pharmacological
8
treatment
8
pharmacological treatment
8
randomised controlled
8

Similar Publications

Article Synopsis
  • The study aimed to assess the effectiveness and safety of indirect moxibustion using a moxa stick in reducing pain and improving quality of life for patients with back myofascitis, comparing it to topical diclofenac sodium gel treatment.
  • Seventy-two patients were split into two groups, with one receiving moxibustion treatment three times a week and the other using the gel three times daily for two weeks.
  • Results showed a significant reduction in pain scores (VAS and SF-MPQ) for the moxibustion group compared to the control group, indicating better pain management and clinical effects.
View Article and Find Full Text PDF

Occlusal interventions for managing temporomandibular disorders.

Cochrane Database Syst Rev

September 2024

Hubei-MOST KLOS & KLOBM, School and Hospital of Stomatology, Wuhan University, Wuhan, China.

Background: Temporomandibular disorders (TMD) are conditions related to the musculoskeletal structure of the temporomandibular joint, which may lead to muscle or joint pain and other health issues. TMD may present in muscles only (myogenous), joints only (arthrogenous), or both (mixed), and may affect one side or both sides of the face. Myogenous TMD may present with or without limited mouth opening.

View Article and Find Full Text PDF

A novel therapeutic approach combining acupuncture and diclofenac sodium (DS) administration was established for the potential treatment for rheumatoid arthritis (RA). DS is a commonly used anti-inflammatory and analgesic drug but has short duration and adverse effects. Acupoints are critical linkages in the meridian system and are potential candidates for drug delivery.

View Article and Find Full Text PDF
Article Synopsis
  • - Alzheimer's disease (AD) is a major neurodegenerative disorder, prompting research into drugs that target specific genes involved in the disease using R software for data analysis of single nuclei transcriptomes.
  • - The analysis identified 564 differentially expressed genes (DEGs), with key hub genes including ISG15, STAT1, and others, and indicated that major biological pathways affected include responses to viruses and interferon signaling.
  • - Molecular docking studies revealed that Diclofenac effectively binds to key genes IFI44 and IFI44L, suggesting that potential drugs may help regulate immune responses and inflammation, potentially aiding in the fight against AD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!